Watch: Biotech Going Up Against Big Pharma

As co-founder, chairman & chief executive of Ocugen, Shankar Musunuri, is looking to bring eye disease products to the patients that big pharma’s drugs have left out. The Malvern, Penn.-based company has four compounds in its pipeline at various stages of development. It’s most advanced candidate, OCU300, is gearing up for Phase III trials in 2018. It’s second candidate, OCU310, combines brimonidine, a drug usually designed for patients with glaucoma, and a steroid. With some of Ocugen’s products, like it’s OCU100 compound designed to delay the progression of retinitis pigmentosa, there is no other drug currently on the market – so there’s no immediate competition. “The goal is to get something to the market to help patients as soon as possible because they don’t have anything today,”

Follow us on social media for the latest updates in B2B!

Image

Latest

modern AI architecture
A Practical Guide to Modern AI Architecture, Workflow-First Thinking, and Scalable Business Value
April 24, 2026

Artificial intelligence has already moved beyond the hype cycle and into the day-to-day reality of business operations. Companies across industries are rushing to integrate AI into their workflows, but many are running into the same challenge: it’s relatively easy to build something that works in a demo, and much harder to make it reliable…

Read More
farm
The Business Case for AgTech: Better Data Is Key to Managing Risk on the Farm
April 23, 2026

Farming is under more pressure than it’s been in years. Costs are rising, prices are unpredictable, and every decision carries more weight than it used to. What many still think of as a traditional industry is quietly evolving, with more farmers turning to digital tools to manage risk and stay competitive. It’s not about chasing…

Read More
pre-clinical
From Classroom to Clinic: Pre-Clinical Talent Steps Into Healthcare’s Hard-to-Fill Roles
April 23, 2026

Healthcare systems are facing a workforce crisis that’s no longer temporary—it’s structural. Even before COVID-19, staffing shortages across nursing, technical, and administrative roles were already straining capacity; today, those gaps are wider, costlier, and directly impacting patient access. With labor shortages persisting and burnout rising, health systems are being forced to rethink not just…

Read More
learning
If Higher Ed Wants Experiential Learning at Scale, It Needs a Broader Playbook
April 21, 2026

The ground is shifting under higher education. AI is changing how people learn almost overnight—and at the same time, more than half of graduates are underemployed after finishing their degrees. That’s forcing a more uncomfortable question into the open: what is a college credential really worth today? As employers and governments shift their focus…

Read More